Rare diseases
Investigational molecules
Locations
Hauptstrasse 2, 82008 Unterhaching, Germany
Neuropraxis Muenchen Sued in Unterhaching, Germany specialises in clinical trials of conditions such as Migraine, Migraine with aura, Migraine without aura, Migraine prophylaxis, and other specialisations. This site conducts important research.
The site is conducting studies on preventive treatment for chronic and episodic migraine. One trial evaluates the safety of atogepant. Another arm assesses the tolerability of topiramate as a comparator.
Neuropraxis Muenchen Sued is dedicated to advancing preventive options for patients living with migraine.
Research at the site focuses on relapsing-remitting multiple sclerosis. A study examines the pharmacokinetic profile of the biosimilar candidate ABP 692. It also compares pharmacodynamic effects with the reference product ocrelizumab.
The work at Neuropraxis Muenchen Sued supports development of more affordable therapies for MS patients.
More sites in UnterhachingGermany
Clinical trials registered at this site – none is enrolling right now.
Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
GermanyStudy Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine
GermanyStudy on Long-Term Safety of Atogepant for Preventing Migraine in Patients with Chronic or Episodic Migraine
GermanyStudy on the Safety and Efficacy of BIIB091 and Diroximel Fumarate for Patients with Relapsing Multiple Sclerosis
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
